Research
Neuroscience Research

• A Multicenter, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy
• Allosteric Modulators of GABA Action in the Etiology of Psychosis
• Aging and Neuronal 5-Lipoxygenase
• Antiretroviral Therapy and Cognition in HIV-1 Infection
• Aripiprazole Versus Perphenazine in the Treatment of Patients with Treatment-Resistant Schizophrenia
• Aripiprazole Versus Placebo for Symptoms of Acute Mania
• Cellular Manifestations of Aging in Rat Olfactory Cortex
• Cognitive Neuropsychology of HIV and Drug Abuse
• Cognitive Neuropsychology of HIV and MDMA Abuse
• The Efficacy and Safety of Single Dose Ranges of Risperidine vs. Placebo in the Treatment of Manic Episodes associated with Bipolar I Disorder
• Neurobiology of Aging in the Mouse Olfactory System
• Benzodiazepines, Long-Term Potentiation, and Memory
• Dopamine Nontolerance to Neuroleptics and Schizophrenia
• Is Fluoxetine's Antidysphoric Effect Mediated by Neurosteriods?
• K+ Efflux: Role in Ca2+ Homeostasis and Excitotoxicity
• Longitudinal Evaluation of Combination Antiretroviral Therapy on Cognitive Deficits in HIV-1 Infected Patients: A Pilot Study
• Molecular Mechanisms of Diazepam Tolerance
• Neurobehavioral Function in HIV-Seropositive Women
• Neurosteriod: Physiological Relevance
• Olanzapine Versus Placebo in Treatment of Bipolar Disorder, Manic or Mixed
• Pharmacology: Allosteric Modulators of GABA Receptors
• Prospective Memory and Medication Adherence in HIV-Seropositive Women
• Role of 5-Lipoxygenase in Brain Aging
• Safety and Efficacy of Depakote as Combination Therapy in the Treatment of Psychosis Associated with Schizophrenia
• Serotengenic Mechanisms in Alcohol Dependence
• Serotonin Receptors and protein Kinase in Depression Vulnerability to Psychosis: The Role of Reelin (RELN) Haploinsufficiency and the Selective Decrease of GAD 67 Levels